Artificial β-cell: clinical experience toward an implantable closed-loop insulin delivery system
- 8 December 2006
- journal article
- conference paper
- Published by Elsevier in Diabetes & Metabolism
- Vol. 32 (5) , 497-502
- https://doi.org/10.1016/s1262-3636(06)72802-6
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Continuous glucose monitoring and closed‐loop systemsDiabetic Medicine, 2005
- Implantable glucose sensors for diabetes monitoringMinimally Invasive Therapy & Allied Technologies, 2004
- Recent advances in continuous glucose monitoringExperimental and Clinical Endocrinology & Diabetes, 2001
- Insulin Underdelivery From Implanted Pumps Using Peritoneal Route: Determinant role of insulin pump compatibilityDiabetes Care, 1996
- Feasibility of Intraperitoneal Insulin Therapy With Programmable Implantable Pumps in IDDM: A multicenter studyDiabetes Care, 1995
- Insulin Antibody Responses After Long-Term Intraperitoneal Insulin Administration via Impiantatile Programmable Insulin Delivery SystemsDiabetes Care, 1994
- French multicentre experience of implantable insulin pumpsThe Lancet, 1994
- Clinical Trial of Programmable Implantable Insulin Pump For Type I DiabetesDiabetes Care, 1992
- A Preliminary Trial of the Programmable Implantable Medication System for Insulin DeliveryNew England Journal of Medicine, 1989
- Evaluation of exogenous insulin homoeostasis by the artificial pancreas in insulin-dependent diabetesDiabetologia, 1977